Immuneering CorporationIMRXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank17
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-59.38M
↓ 43% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-41.55M
Historical baseline
PeriodValueYoY Change
TTM$-59.38M+7.3%
2024$-64.07M-9.7%
2023$-58.41M-12.9%
2022$-51.74M-52.7%
2021$-33.89M-98.4%
2020$-17.08M-171.5%
2019$-6.29M-